NSG6005 Pharm Test Week 3
NSG6005 Pharm Test Week 3 Chapter 2. Review of Basic Principles of Pharmacology ____ 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to prescribing because: ____ 2. Drugs that have a significant first-pass effect: ____ 3. The route of excretion of a volatile drug will likely be the: ____ 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage reservoir of the drug. Storage reservoirs: ____ 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s: ____ 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the prescription. This is considered a loading dose. A loading dose: ____ 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect is the: ____ 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done: ____ 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration. This means that the: ____ 10. Drugs that are receptor agonists may demonstrate what property? ____ 11. Drugs that are receptor antagonists, such as beta blockers, may cause: ____ 12. Factors that affect gastric drug absorption include: ____ 13. Drugs administered via IV: ____ 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is: ____ 15. Which of the following statements about bioavailability is true? ____ 16. Which of the following statements about the major distribution barriers (blood-brain or fetal-placental) is true? ____ 17. Drugs are metabolized mainly by the liver via phase I or phase II reactions. The purpose of both of these types of reactions is to: ____ 18. Once they have been metabolized by the liver, the metabolites may be: ____ 19. All drugs continue to act in the body until they are changed or excreted. The ability of the body to excrete drugs via the renal system would be increased by: ____ 20. Steady state is: ____ 21. Two different pain medications are given together for pain relief. The drug—drug interaction is: ____ 22. Actions taken to reduce drug—drug interaction problems include all of the following EXCEPT: ____ 23. Phase I oxidative-reductive processes of drug metabolism require certain nutritional elements. Which of the following would reduce or inhibit this process? ____ 24. The time required for the amount of drug in the body to decrease by 50% is called: ____ 25. An agonist activates a receptor and stimulates a response. When given frequently over time, the body may: ____ 26. Drug antagonism is best defined as an effect of a drug that: ____ 27. Instructions to a client regarding self-administration of oral enteric-coated tablets should include which of the following statements? ____ 28. The major reason for not crushing a sustained-release capsule is that, if crushed, the coated beads of the drugs could possibly result in: ____ 29. Which of the following substances is the most likely to be absorbed in the intestines rather than in the stomach? ____ 30. Which of the following variables is a factor in drug absorption? ____ 31. An advantage of prescribing a sublingual medication is that the medication is: ____ 32. Drugs that use CYP 3A4 isoenzymes for metabolism may: ____ 33. Therapeutic drug levels are drawn when a drug reaches steady state. Drugs reach steady state: ____ 34. Upregulation or hypersensitization may lead to:……………………………………………………CONTINUED………………………….
Información del documento
- Subido en
- 21 de enero de 2021
- Número de páginas
- 11
- Escrito en
- 2020/2021
- Tipo
- Examen
- Contiene
- Preguntas y respuestas